Trial Profile
Phase 2 study of KVD818 in in patients with hereditary angioedema
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs KVD 818 (Primary)
- Indications Hereditary angioedema
- Focus Therapeutic Use
- 01 Sep 2016 New trial record